CASI Pharmaceuticals, Inc. (CASIF): SCHEDULE 13D/A filed Feb 3, 2025

Form type

SCHEDULE 13D/A

Filing date

Feb 3, 2025

Accession number

0000929638-25-000503

Filer

CASI Pharmaceuticals, Inc. (CIK 1962738)